Filter Results:
(111)
Show Results For
- All HBS Web
(111)
- News (22)
- Research (69)
- Events (1)
- Multimedia (3)
- Faculty Publications (48)
Show Results For
- All HBS Web
(111)
- News (22)
- Research (69)
- Events (1)
- Multimedia (3)
- Faculty Publications (48)
Arjun Goyal
Medicines (NASDAQ:FIXX), Pionyr Immunotherapeutics (acquired by Gilead), Peloton Therapeutics (acquired by Merck & Co.), and Asklepios Bio (acquired by Bayer). Before co-founding Vida Ventures in 2017, Arjun was a life sciences... View Details
Keywords: Finance
Arjun Goyal
Merck & Co.), and Asklepios Bio (acquired by Bayer). Before co-founding Vida Ventures in 2017, Arjun was a life sciences investor at 5AM Ventures. Arjun received his B.Sc. in Medical Science, Diploma in French and his MBBS degree from the... View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
science-based research is something the heads of top biotech and pharmas learned long ago: There are few instant payoffs to please investors. Just ask Raymond Gilmartin, former chairman, president, and CEO of Merck & Co., who now... View Details
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
a rapidly changing landscape that presents increasingly complex management challenges, leadership skills are even more essential to a venture's success, Pisano said. "A good business model is necessary but not sufficient," he stated. Raymond Gilmartin (MBA '68),... View Details
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
- 24 Aug 2020
- Blog Post
My Journey to Joining the first MS/MBA Biotechnology: Life Sciences Cohort
at Merck in their Screening and Protein Sciences Department. There, we ran tests to identify potential therapeutic candidates. Through this research, I started to see the link between bench science and the impact that science can have on... View Details
- 01 Dec 2002
- News
Alumni Honorees Urge Students to Emphasize Ethics
2002 Alumni Achievement Awards Raymond V. Gilmartin (MBA '68) Chairman, President, and CEO, Merck & Co. Since June 1994, when Gilmartin became its president and CEO, Merck has launched seventeen new drugs... View Details
- 06 Sep 2017
- What Do You Think?
Summing Up: What Are the Limits of CEO Activism?
suggesting that “both sides”—one group that included neo-Nazis and the KKK and another group of counter-protesters—were to blame for the violence, injuries, and deaths on or near the University of Virginia campus last month. This prompted View Details
Keywords: by James Heskett
- 01 Oct 1997
- News
Class of 1997 Graduates with Distinction
Gilmartin (MBA '68). Gilmartin is chairman, president, and CEO of Merck & Co., Inc., and the father of Beth A. Gilmartin, a member of this year's graduating class. A reception followed for students, family, and friends. After attending... View Details
- 18 Apr 2017
- First Look
First Look at New Ideas, April 18
M&A) and Werner Baumann (CFO) have to decide whether to increase the cash portion of their $14.2 billion offer and/or amend the terms of a proposed joint venture (JV) with Merck involving cardiovascular drugs that had been included in... View Details
Keywords: by Sean Silverthorne
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
[Image: aleksejplatonov] Related Reading The COVID Gender Gap: Why Fewer Women Are Dying COVID's Surprising Toll on Careers of Women Scientists Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk... View Details
- 30 Apr 2001
- Research & Ideas
Entering the Age of Alliances
been collaborating for three years to increase the number of African American biologists and chemists. In 1995, they launched the UNCF Merck Science Internships. The undergraduates, doctoral students, and postdoctoral scientists who... View Details
Keywords: by James Austin
- 02 Oct 2000
- Research & Ideas
The Dubious Logic of Global Megamergers
moves itself. According to industry observers, Merck intends to use this period in which its competitors are busy with postmerger integration to improve its position through aggressive marketing and other initiatives. Make Friends.... View Details
Keywords: by Pankaj Ghemawat & Fariborz Ghadar
- 18 Aug 2017
- Op-Ed
Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump
companies like Frazier and Merck got from the President. Their companies have products dependent on government approvals and major regulatory issues before Congress and the administration. Given these issues, what does it take for a CEO... View Details
Keywords: by Bill George
- 01 May 2007
- First Look
First Look: May 1, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207113 Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc. Harvard Business School Case 707-509 The global pharmaceutical industry has gone... View Details
Keywords: Sean Silverthorne
- 16 Nov 2021
- News
Getting Back Together for Global Networking Night; Healthcare Conference Draws New Interest
opportunities during breaks included virtual chats as well as a few small, COVID-safe in-person gatherings, primarily located in the Boston area. During the event, the association honored Kenneth C. Frazier, Executive Chairman of the Board of View Details
Keywords: Margie Kelley
- 31 Jul 2012
- First Look
First Look: July 31
Confidential Instructions for Johnson & Johnson Guhan Subramanian and Rhea GhoshHarvard Business School Exercise 911-045 This two-party negotiation exercise features a real-life dispute between Merck and Johnson & Johnson... View Details
Keywords: Carmen Nobel
- 20 May 2019
- Research & Ideas
Activist CEOs Are Rising Up—and Their Customers Are Listening
When former Starbucks CEO Howard Schultz announced earlier this year he was thinking about running for president of the United States, it wasn’t a new idea. Past CEOs seeking the White House have included Carly Fiorina, Ross Perot, Herman Cain, Steve Forbes, Mitt... View Details
Keywords: by Michael Blanding
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
including Bohmer, a physician; Bill George, former chairman and CEO of Medtronic; Raymond Gilmartin, former chairman, president, and CEO of Merck & Co.; Robert Huckman, a former health care consultant and now Faculty Research Fellow... View Details
- 01 Apr 2000
- News
Real World Issues Aired at Student Led Conferences
while the second offered the opportunity to learn more about careers in entertainment and media, high tech, marketing, and nonprofits. Judy Lewent, SVP and CFO of Merck & Co., another of Fortune's top fifty, delivered the second keynote... View Details
Keywords: Mary Ellen Gardner